A detailed history of Breed'S Hill Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Breed'S Hill Capital LLC holds 7,440 shares of ABBV stock, worth $1.25 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
7,440
Previous 7,442 0.03%
Holding current value
$1.25 Million
Previous $1.28 Billion 15.1%
% of portfolio
1.2%
Previous 1.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$163.84 - $199.33 $327 - $398
-2 Reduced 0.03%
7,440 $1.47 Billion
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $31,964 - $36,420
-200 Reduced 2.62%
7,442 $1.36 Billion
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $1.05 Million - $1.18 Million
7,642 New
7,642 $1.18 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Breed'S Hill Capital LLC Portfolio

Follow Breed'S Hill Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Breed'S Hill Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Breed'S Hill Capital LLC with notifications on news.